Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Current Liabilities

The Current Liabilities of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Nov 16, 2026 is 156.97 M CNY. In the previous year, Current Liabilities was 1.66 B CNY — a change of -90.56% (lower).

Current Liabilities

156.97 MCNY

YoY

-90.56%

Last updated:

Current Liabilities of Vcanbio Cell & Gene Engineering Corp is 2025 156.97 M CNY. Current Liabilities of Vcanbio Cell & Gene Engineering Corp was 2024 1.66 B CNY. It decreases by -90.56% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
1.29 B CNY
Jan 1, 2019
1.33 B CNY
Jan 1, 2020
213.45 M CNY
Jan 1, 2021
260.24 M CNY
Jan 1, 2022
467.21 M CNY
Jan 1, 2023
486.33 M CNY
Jan 1, 2024
1.66 B CNY
Jan 1, 2025
156.97 M CNY
The Vcanbio Cell & Gene Engineering Corp Current Liabilities history
YEARCurrent LiabilitiesYoY
156.97 MCNY-90.56%
1.66 BCNY+241.83%
486.33 MCNY+4.09%
467.21 MCNY+79.53%
260.24 MCNY+21.92%
213.45 MCNY-83.94%
1.33 BCNY+2.97%
1.29 BCNY+8.69%
1.19 BCNY+0.51%
1.18 BCNY+7.92%
1.09 BCNY-8.95%
1.20 BCNY+45.68%
825.38 MCNY-13.77%
957.15 MCNY+61.35%
593.20 MCNY+17.34%
505.53 MCNY+17.48%
430.30 MCNY+8.62%
396.14 MCNY+8.29%
365.80 MCNY-6.98%
393.23 MCNY+27.14%
309.29 MCNY+10.37%
280.22 MCNY+4.01%
269.41 MCNY+29.22%
208.48 MCNY-33.08%
311.52 MCNY+29.30%
240.92 MCNY-11.39%
271.89 MCNY+3.52%
262.65 MCNY-3.48%
272.12 MCNY+53.90%
176.81 MCNY-2.88%
182.05 MCNY+85.46%
98.16 MCNY+133.93%
41.96 MCNY+75.00%
23.98 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp., Ltd. generates revenue through the development and sale of life sciences technology products. The company produces cytokines culture solutions, cosmetics, and detection reagents for domestic markets. Its business segments include cell culture, gene detection and storage, and the production of specialized biological products. The firm's domestic customers primarily purchase these products for research and commercial applications in the life sciences sector. Vcanbio focuses on cell culture and gene detection services, which are integral to its product offerings. The company's cytokines culture solutions are sold to domestic clients in the biotechnology and pharmaceutical industries. Detection reagents are also marketed to domestic laboratories and healthcare providers for diagnostic purposes. The firm leverages its 2,332 full-time employees to support research, development, and production activities. The company's product portfolio includes cosmetics alongside scientific reagents, targeting both consumer and professional markets. Domestic markets remain the primary focus for all sales, with no mention of international operations. Vcanbio's revenue streams are derived from the sale of its core products, which are developed and manufactured in-house. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Current Liabilities of Vcanbio Cell & Gene Engineering Corp is 156.97 M CNY in 2025.

Current Liabilities of Vcanbio Cell & Gene Engineering Corp changed from 1.66 B CNY to 156.97 M CNY, representing a -90.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Vcanbio Cell & Gene Engineering Corp

All Key Metrics — Vcanbio Cell & Gene Engineering Corp